BOULDER, Colo., January 12, 2026 – Mandara Biopharma Inc., a privately held U.S.-based biopharmaceutical company focused on novel therapies for central nervous system (CNS) disorders, today announced that it has filed an Investigational New Drug (IND) application with the U.S. Food and Drug Administration (FDA) to...

read more